We are live on
!
Find out more
AQR Capital Management Portfolio holdings
AUM
$218B
1-Year Est. Return
29.41%
This Fund
S&P 500
This Quarter
Est. Return
+12.21%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$53.1B
AUM Growth
+$4.7B
(+9.7%)
Cap. Flow
-$415M
Cap. Flow
% of AUM
-0.78%
Top 10 Holdings %
Top 10 Hldgs %
15.39%
Holding
2,495
New
186
Increased
937
Reduced
1,188
Closed
172
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$144M |
| 2 |
NVIDIA
NVDA
|
+$137M |
| 3 |
GE Aerospace
GE
|
+$129M |
| 4 |
Dell
DELL
|
+$91.3M |
| 5 |
Comcast
CMCSA
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$103M |
| 2 |
Microchip Technology
MCHP
|
+$98.3M |
| 3 |
Steel Dynamics
STLD
|
+$87M |
| 4 |
UnitedHealth
UNH
|
+$79.5M |
| 5 |
Walmart Inc
WMT
|
+$79.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.58% |
| 2 | Consumer Discretionary | 13.58% |
| 3 | Healthcare | 12.97% |
| 4 | Financials | 12.15% |
| 5 | Industrials | 12.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
First Hawaiian
FHB
$3.35B
| $534K | ﹤0.01% |
23,350
+2,936
| +14% | +$57.4K |
|
1852
Krystal Biotech
KRYS
$9.78B
| $534K | ﹤0.01% |
4,302
+288
| +7% | +$31.9K |
|
|
NOTV
1853
DELISTED
Inotiv
NOTV
| $529K | ﹤0.01% |
144,168
-262,628
| -65% | -$663K |
|
1854
Dominion Energy
D
$59.2B
| $529K | ﹤0.01% |
11,299
-173,412
| -94% | -$7.74M |
|
|
PPBI
1855
DELISTED
Pacific Premier Bancorp
PPBI
| $528K | ﹤0.01% |
+18,153
| New | +$422K |
|
1856
Tenaris
TS
$27B
| $528K | ﹤0.01% |
15,195
-17,196
| -53% | -$576K |
|
|
SNBR
1857
DELISTED
Sleep Number
SNBR
| $528K | ﹤0.01% |
+35,614
| New | +$553K |
|
1858
Evolus
EOLS
$517M
| $528K | ﹤0.01% |
50,153
-2,588
| -5% | -$23.1K |
|
|
CBAY
1859
DELISTED
Cymabay Therapeutics
CBAY
| $526K | ﹤0.01% |
22,270
-9,839
| -31% | -$175K |
|
1860
Schwab US Large-Cap Growth ETF
SCHG
$63B
| $524K | ﹤0.01% |
+25,276
| New | +$489K |
|
1861
Alector
ALEC
$199M
| $524K | ﹤0.01% |
65,667
+1,870
| +3% | +$11.1K |
|
1862
uniQure
QURE
$3.14B
| $522K | ﹤0.01% |
77,161
-58,289
| -43% | -$385K |
|
1863
Astec Industries
ASTE
$998M
| $522K | ﹤0.01% |
14,037
-498
| -3% | -$18.4K |
|
1864
Mine Safety
MSA
$7.47B
| $520K | ﹤0.01% |
3,082
+285
| +10% | +$46.3K |
|
1865
Vanguard Communication Services ETF
VOX
$5.89B
| $520K | ﹤0.01% |
4,414
| – | – |
|
1866
SI-BONE Inc
SIBN
$853M
| $520K | ﹤0.01% |
24,753
+13,434
| +119% | +$249K |
|
1867
America Movil
AMX
$70.6B
| $518K | ﹤0.01% |
27,960
-120,839
| -81% | -$2.12M |
|
1868
Karyopharm Therapeutics
KPTI
$46.2M
| $517K | ﹤0.01% |
39,876
+6,423
| +19% | +$86.5K |
|
1869
Rush Street Interactive
RSI
$2.92B
| $516K | ﹤0.01% |
114,876
+47,505
| +71% | +$197K |
|
1870
California Water Service
CWT
$3.05B
| $515K | ﹤0.01% |
9,934
-14,209
| -59% | -$715K |
|
|
ALPN
1871
DELISTED
Alpine Immune Sciences Inc
ALPN
| $514K | ﹤0.01% |
+26,970
| New | +$375K |
|
1872
Cosan
CSAN
$2.59B
| $513K | ﹤0.01% |
32,786
+1,617
| +5% | +$22.6K |
|
1873
iShares MSCI India ETF
INDA
$6.6B
| $513K | ﹤0.01% |
10,513
+1,898
| +22% | +$86.3K |
|
1874
Cytek Biosciences
CTKB
$595M
| $513K | ﹤0.01% |
56,206
+17,167
| +44% | +$108K |
|
|
HDSN
1875
Hudson Technologies
HDSN
$237M
| $507K | ﹤0.01% |
37,559
-4,296
| -10% | -$55.5K |
|
Similar funds
VGA
AQR Capital Management's Q4 2023 Portfolio in Review
As of Q4 2023, AQR Capital Management held 2,495 positions worth $53.1B, up 9.7% from $48.4B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
AQR Capital Management's Q4 2023 filing shows 186 new, 937 increased, 1,188 reduced and 172 closed positions. Its largest new stake was NCR Atleos: 518,383 shares worth $12.5M. The largest sale was Pfizer, an estimated $103M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 23% a quarter earlier, followed by Consumer Discretionary and Healthcare.
- AQR Capital Management's largest Q4 2023 buy was NCR Atleos: 518,383 shares worth $12.5M.
- AQR Capital Management added most to Amazon in Q4 2023, an estimated $144M increase.
- AQR Capital Management's biggest Q4 2023 reduction was Pfizer, cutting an estimated $103M.
- AQR Capital Management fully exited Activision Blizzard in Q4 2023, selling an estimated $38.5M.
- AQR Capital Management's ten largest holdings make up 15% of its $53.1B portfolio in Q4 2023.
- AQR Capital Management opened 186 new positions and closed 172 in Q4 2023.
- AQR Capital Management's portfolio value rose 9.7% quarter-over-quarter to $53.1B.
Based on AQR Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.